Avista doubles API capacity in Colorado
Avista Pharma has added a fourth GMP suite at its Longmont facility as part of an investment of more than $20m in its manufacturing operations.
Avista Pharma has added a fourth GMP suite at its Longmont facility as part of an investment of more than $20m in its manufacturing operations.
AAPS 2017
Quotient Clinical unveiled its new identity at AAPS – and today, has announced another acquisition as the company looks to represent “a new class of business,” says CEO.
NEWS IN BRIEF
Quality Pharma Ingredients – a subsidiary of BioStem Technologies – is expanding its API facility in Oakland Park, Florida, US.
Dotmatics has expanded its workflow capabilities to capture experiments and processes, and track projects for biologics discovery.
The Danish Medicines Agency (DKMA) has banned Europharma from performing manufacturing activities citing a general lack of will and ability to adhere to GMP.